Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in non-ST elevation acute coronary syndromes
2006-001767-31Phase 2Completed
- Sponsor
- University of Sheffield
- Start
- Feb 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute coronary syndrome (ACS) and Non-ST-segment elevation myocardial infarction (NSTEMI) comparing Kineret with Placebo (2 arms). Primary endpoint: Area under the curve of serum hsCRP over the first 7 days. Started Feb 2008; status: completed.
02
Drugs
anakinra
03
Conditions
acute coronary syndrome (ACS)Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on 2006-001767-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001767-31.